CannaMD

AUGUST 26, 2020

Find out more about the studies scientists reviewed – and why they think cannabis could help cocaine addiction – below! Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., Current Cocaine Treatments. mice/rats).

Therapy 98

Therapy CBD Research and Development Treatment 98

The Cannigma

JANUARY 13, 2023

Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. Cannabis users have been reporting anecdotal relief for years, but it’s only recently that research has begun to dig into the complexities of migraines and how – or why – cannabis may be able to bring relief.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

JUNE 10, 2021

In short the study learns that legalized states tend not to have their roads overcrowded with stoned drivers and cannabis users like alcohol users self police their behaviour. The prevalence of cannabis-involved driving in California. Cannabis effects on driving skills. J Anal Toxicol. 2014;38(8):569–74. Drug Alcohol Depend.

Policy 59

Policy Safety Marijuana Data 59

The Cannigma

OCTOBER 19, 2021

Taken responsibly, both alcohol and cannabis can be a great time. If you’re old enough, you may remember hearing in the anti-drug class at school that when taken together, alcohol and cannabis double the effects of one another. But are the results different for more frequent cannabis users? But what about when you mix the two?

Research and Development 128

Research and Development Clinical Trials Edibles THC 128

Cannabis Law Report

JULY 12, 2019

New private clinics offering medical cannabis in the UK. The Medical Cannabis Clinic has revealed that it will be opening its flagship clinic in London, in Harley Street, this summer. Background to the legalisation of medical cannabis in the UK.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

Cannabis Law Report

AUGUST 2, 2021

(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

NOVEMBER 13, 2019

Denmark’s pilot pharma trial attracts first-movers. Europe, forecasted to be the world’s biggest legal cannabis market by 2024 will exceed North America, the dominant market today, according to Prohibition Partners. If Canadian companies want to export cannabis, it takes approximately two-to-three months to secure an export permit.

Clinical Trials 78

Clinical Trials Research and Development Cultivation Patients 78

Cannabis Law Report

NOVEMBER 24, 2021

Medical publications, are, in the main fairly positive toward cannabis. Published by The Journal of Cannabis Research. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. At the same time, the outlook on cannabis research data is largely positive. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. a leading biotech company in the hemp and cannabis industries. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/ronanlevy/. Shlomi Raz.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. No hepatic side effects were noted.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

OCTOBER 17, 2019

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. This white paper offers a primer to the complex and confusing global cannabis industry as it stands today.

Law 40

Law Seed-To-Sale Hemp Recreational 40